Revance Therapeutics, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Revance Therapeutics' 10-K filing highlights a year of commercial expansion, strategic shifts, and continued investment in its aesthetics and therapeutics portfolio, while also detailing financial performance and future outlook.